Your browser doesn't support javascript.
loading
Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer.
Zhang, Yi; Tacheva-Grigorova, Silvia K; Sutton, Janette; Melton, Zea; Mak, Yvonne S L; Lay, Cecilia; Smith, Bryan A; Sai, Tao; Van Blarcom, Thomas; Sasu, Barbra J; Panowski, Siler H.
Affiliation
  • Zhang Y; Allogene Therapeutics, South San Francisco, California.
  • Tacheva-Grigorova SK; Allogene Therapeutics, South San Francisco, California.
  • Sutton J; Allogene Therapeutics, South San Francisco, California.
  • Melton Z; Allogene Therapeutics, South San Francisco, California.
  • Mak YSL; Allogene Therapeutics, South San Francisco, California.
  • Lay C; Allogene Therapeutics, South San Francisco, California.
  • Smith BA; Allogene Therapeutics, South San Francisco, California.
  • Sai T; Pfizer Worldwide Research and Development, South San Francisco, California.
  • Van Blarcom T; Allogene Therapeutics, South San Francisco, California.
  • Sasu BJ; Allogene Therapeutics, South San Francisco, California.
  • Panowski SH; Allogene Therapeutics, South San Francisco, California.
Clin Cancer Res ; 29(5): 971-985, 2023 03 01.
Article in En | MEDLINE | ID: mdl-36692420
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Small Cell Lung Carcinoma / Lung Neoplasms Limits: Animals Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Small Cell Lung Carcinoma / Lung Neoplasms Limits: Animals Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Type: Article